Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Market breadth depicted strength. There were almost 3 gainers against every loser on BSE
Some of the popular brands that would be impacted include Phensedyl (Abbott), Tixylix (Abbott), Gluconorm PG (Lupin), Ascoril D (Glenmark), Solvin Cold (Ipca), D Cold Total (Paras Pharma).
The FIPB rejected two proposals -- Nigeria's Mokeme Chiwetal Izuchukwu and Lanarth Developers Pvt Ltd.
The six service lines that Infosys is focusing on include manufacturing, retail, consumer packaged goods, logistics, lifescience, energy, communications, financial services and insurance.
DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices
Ratan Tata said he continued to feel the need to support young entrepreneurs who were keen to unleash the Indian tiger.
Revenues rose 7.7 per cent to $1.54 billion during the review period, from $1.43 billion in the corresponding quarter last fiscal.
The founders of Gland Pharma, led by Ravi Penmetsa, and KKR, together own 96 per cent of the company.
Pharma shares were the top gainers led by Lupin after the company received EIR from USFDA for its Goa facility
Global private equity (PE) major Carlyle is in talks with renowned cardiac surgeon Dr Naresh Trehan to acquire a minority stake in his Gurgaon-based multi-super speciality hospital, Medanta -The Medicity.
The European Medicines Agency's review is the second setback to Alkem Laboratories
Food regulator has closed more than 15 files.
The S&P BSE Sensex closed 318 points at 24,455 and the Nifty50 shed 99 points to end at 7,438.
The move assumes significance because a go-ahead from the US Food and Drug Administration for the new unit in Visakhapatnam is likely to give a huge boost to the company's revenues in upcoming quarters.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries:
The BSE Midcap ended up 0.5% while the Smallcap index ended nearly 1% higher
The Delhi High Court on Friday stayed the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.
Since its peak, the S&P BSE Sensex has dropped nearly 3,000 points.
As and when the GST comes in, Budget projections will have to be unbundled and revised. In fact, the pragmatic decision would be to present another Budget! This makes the passage of the Finance Bill with its multiple unrelated amendments seem even more dubious, says Devangshu Datta.
Top gainers from the Sensex pack are Asian Paints, Bajaj Auto, ITC, NTPC, L&T and HDFC, all up 2% each
Natco Pharma, Wockhardt and Marksans have rallied between 50 and 70 per cent in the year till date.
The FMCG index gained more than 1% on the back of stellar gains in ITC.
The 30-share Sensex ended down 261 points at 27,177 and the 50-share Nifty ended down 91 points at 8,214.
Sensex was up 184 points at 25,580 and the Nifty added 71 points to end the day at 7,654
'We expect the new government to look into the issue of penalties imposed on technology firms involved in UID related projects.'
The category is expected to cross Rs 38,400 crore by 2020.
'Let me talk about young Indian startups with their hearts in the right place and how they are proving that innovations that represent 'affordable excellence' -- breaking the myth that 'affordability' and 'excellence' cannot go together -- is indeed possible!' says Dr R A Mashelkar, the eminent scientist, in this fascinating feature.
Armed with green nod and fund infusion, Gujarat govt getting ready to issue tenders to build infrastructure at the mega investment region
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances